This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

NICE - insulin therapy in type 1 diabetes

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Insulin regimens

  • multiple daily injection basal-bolus insulin regimens should be offered rather than twice-daily mixed insulin regimens, as the insulin injection regimen of choice for all adults with type 1 diabetes

Long-acting insulin

  • twice-daily insulin detemir should be offered as basal insulin therapy for adults with type 1 diabetes

  • consider, as an alternative basal insulin therapy for adults with type 1 diabetes:
    • an existing insulin regimen being used by the person that is achieving their agreed targets

    • once-daily insulin glargine or insulin detemir if twice-daily basal insulin injection is not acceptable to the person, or once-daily insulin glargine if insulin detemir is not tolerated

Rapid-acting insulin

  • rapid-acting insulin analogues injected before meals should be offered, rather than rapid-acting soluble human or animal insulins, for mealtime insulin replacement for adults with type 1 diabetes
  • do not advise routine use of rapid-acting insulin analogues after meals for adults with type 1 diabetes
  • if an adult with type 1 diabetes has a strong preference for an alternative mealtime insulin, respect their wishes and offer the preferred insulin

Mixed insulin in type 1 diabetes

  • a twice-daily human mixed insulin regimen for adults with type 1 diabetes can be considered if a multiple daily injection basal-bolus insulin regimen is not possible and a twice-daily mixed insulin regimen is chosen

  • a trial of a twice-daily analogue mixed insulin regimen can be considered if an adult using a twice-daily human mixed insulin regimen has hypoglycaemia that affects their quality of life

Optimising insulin therapy

  • for adults with erratic and unpredictable blood glucose control (hyperglycaemia and hypoglycaemia at no consistent times), rather than a change in a previously optimised insulin regimen, the following should be considered:
    • injection technique
    • injection sites
    • self-monitoring skills
    • knowledge and self-management skills
    • nature of lifestyle
    • psychological and psychosocial difficulties
    • possible organic causes such as gastroparesis

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.